Frontage Holdings Corp is Frontage Holdings Corp (Frontage), a subsidiary of Hong Kong Tigermed Co Ltd, is a biotechnology company that provides contract research organization. The company focused on drug candidate evaluation solutions, product development and CMC solutions, clinical services solutions and central laboratories and testing. Its drug candidate evaluation services comprise organic chemistry services, safety and toxicology, bioanalytical and genomics. Frontage clinical services include clinical study experience, BE/BA studies, biometrics and data management. The company also provides central laboratories and testing and COVID-19 capabilities and testing services. It serves pharma, medical and life science companies. The company has operations in the US and China. Frontage is headquartered in Exton, Pennsylvania, the US.
Headquarters
United States of America
Address
700 Pennsylvania Dr, Exton, 19341-1129
Website
www.frontagelab.com
Telephone
1 610 2320100
No of Employees
1,613
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
1521 (HKG)
Revenue (2022)
$250.4M
35.7%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
39.7%
(2022 vs 2021)
Market Cap*
$353.3M
Net Profit Margin (2022)
XYZ
2.9%
(2022 vs 2021)
* As of and is in US$
Frontage Holdings Corp premium industry data and analytics
Products and Services
| Services |
|---|
| Drug Candidate Evaluation Solutions: |
| Organic Chemistry Services |
| Bioanalytical |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | Frontage Holdings Corp | SciClone Pharmaceuticals Holdings Ltd | HitGen Inc | CARsgen Therapeutics Ltd | Labcorp Drug Development |
|---|---|---|---|---|---|
| Headquarters | United States of America | China | China | China | United States of America |
| City | Exton | Shanghai | Chengdu | Shanghai | Burlington |
| State/Province | Pennsylvania | Shanghai | Sichuan | Shanghai | North Carolina |
| No. of Employees | 1,613 | 1,000 | 508 | 525 | 26,000 |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Song Li | Chairman | Executive Board | 2021 | 65 |
| Zhihe Li | Director | Executive Board | 2018 | 68 |
| Abdul Ezaz Mutlib | Chief Executive Officer | Senior Management | 2023 | 62 |
| Henry Gao | President - Asia Pacific; Chief Financial Officer | Senior Management | 2024 | - |
| Dongmei Wang | Executive Vice President | Senior Management | 2017 | 59 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward